Efficacy and Safety of Chinese Botanical Drug Decoctions for Migraine

Fan Zhang published a meta-analysis dataset on 2026-05-01. It aggregates results from 57 randomized controlled trials involving 6,005 patients. The data compares the efficacy and safety of different Chinese botanical drug decoctions for migraine treatment.

Use Cases

• Compare treatment efficacy rankings based on the reported Surface Under the Cumulative Ranking Curve (SUCRA) values.
• Analyze relationships between specific decoctions (e.g., Sanpian Decoction, Xuefu Zhuyu Decoction) and migraine outcome measures like pain intensity and attack frequency.
• Validate Bayesian network meta-analysis models using the reported study parameters, including 50,000 iterations and a 20,000-iteration burn-in period.

Strengths

• Aggregates data from 57 randomized controlled trials, providing a substantial evidence base.
• Includes results for 6,005 patients, offering a meaningful sample size for analysis.
• Uses a systematic review methodology with a pre-registered protocol (PROSPERO CRD420251176748).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The description notes findings should be interpreted with caution due to variability in study quality.

Provenance

Source

figshare

Collection Method

Systematic review and Bayesian network meta-analysis of seven electronic databases.

Time Range

Studies searched from database inception to 20 October 2025.

Freshness

Last updated 2026-05-01 05:24:32; freshness should be verified.

Geography

Likely contains studies from Chinese and international databases (CNKI, Wanfang, VIP, PubMed, etc.), but specific geographic coverage is not stated.